日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myeloma

双特异性BAFF-R/BCMA CAR T细胞控制多发性骨髓瘤中异质性浆细胞的生长

Fiori, Agnese; Zimmermann, Karin; Li, Anna; Westermann, Jörg; Anagnostopoulos, Ioannis; Menzel, Lutz; Bunse, Mario; Erdlei, Henry; Jayarajan, Jeyan; Grünschläger, Florian; Ortiz-Aguirre, Juan Pablo; Haas, Simon; Teßmann, Uwe-Jens; Freitag, Jens; Rosenwald, Andreas; Kwak, Larry; Wang, Xiuli; Dong, Zhenyuan; Cha, Soungchul; Reiser, John; Peralta, Eigen; Valamehr, Bahram; Krönke, Jan; Höpken, Uta E; Rehm, Armin

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial

诱导多能干细胞来源的CD19靶向嵌合抗原受体自然杀伤细胞治疗B细胞淋巴瘤:一项I期首次人体试验

Ghobadi, Armin; Bachanova, Veronika; Patel, Krish; Park, Jae H; Flinn, Ian; Riedell, Peter A; Bachier, Carlos; Diefenbach, Catherine S; Wong, Carol; Bickers, Cara; Wong, Lilly; Patel, Deepa; Goodridge, Jode; Denholt, Matthew; Valamehr, Bahram; Elstrom, Rebecca L; Strati, Paolo

A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape

一种新型CD3ε融合受体使得T细胞衔接器能够应用于不含TCR的同种异体CAR-T细胞中,从而提高其活性并防止抗原逃逸。

Lu, Dan; Chu, Hui-Yi; Park, Soo; Landon, Mark; Tsuda, Masanao; Avramis, Earl; Dege, Carissa; Dailey, Thomas; Pan, Yijia; Hanok, Sandeep Kothapally; Denholtz, Matthew; Abujarour, Ramzey; Lee, Tom; Goulding, John; Hosking, Martin; Goodridge, Jodie; Peralta, Eigen; Valamehr, Bahram

iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors

利用 CAR、TCR 和 hnCD16 等技术改造的 iPSC 衍生三模式 T 细胞可以克服异质性肿瘤中的抗原逃逸。

Bi-Huei Yang ,Alma Gutierrez ,Angela Liao ,Soheila Shirinbak ,Bjoern Gaertner ,Mochtar Pribadi ,Hui-Yi Chu ,Pei-Fang Tsai ,Yu-Sheng Eason Lin ,David Gonzalez ,Wen-I Yeh ,Chia-Wei Chang ,Ryan Bjordahl ,Tom Lee ,Martin Hosking ,Eigen Peralta ,Bahram Valamehr

FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy

FT538,即iPSC衍生的NK细胞,与化疗联合使用时可增强对AML细胞的杀伤作用。

Amanda Eckstrom ,Anudishi Tyagi ,Sajid Mahmood ,Lilly Wong ,Bahram Valamehr ,Adishwar Rao ,Akriti Agrawal ,Maryam Siddiqui ,V Lokesh Battula

Massive scrotal and abdominal subcutaneous emphysema secondary to intrascrotal heroin injection: A case report

阴囊内注射海洛因引起的巨大阴囊和腹部皮下气肿:病例报告

Saberi, Narjes; Rajaei Rizi, Farid; Valamehr, Mahmoud

Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cells.

NKG2A 表达的切换驱动 iPSC 衍生 CAR NK 细胞的功能特化

Kanaya Minoru, Philippon Camille, Netskar Herman, Saetersmoen Michelle Lu, Cieslar-Pobuda Artur, Torralba-Raga Lamberto, Casoni Giovanna Perinetti, Hammer Quirin, Vincenti Marianna, Wiiger Merete Thune, Krokeide Silje Zandstra, Hoel Hanna Julie, Ask Eivind Heggernes, Kosugi-Kanaya Mizuha, Kveberg Lise, Chu Hui-Yi, Groff Brian, Miller Jeffrey S, Lee Tom, Kaufman Dan S, Goodridge Jode P, Valamehr Bahram, Pfefferle Aline, Malmberg Karl-Johan

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies

基因敲除黏附配体可减轻同种异体细胞免疫疗法的排斥反应

Quirin Hammer,Karlo Perica,Rina M Mbofung,Hanna van Ooijen,Karen E Martin,Pouria Momayyezi,Erika Varady,Yijia Pan,Mark Jelcic,Brian Groff,Ramzey Abujarour,Silje Z Krokeide,Tom Lee,Alan Williams,Jode P Goodridge,Bahram Valamehr,Björn Önfelt,Michel Sadelain,Karl-Johan Malmberg

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

CXCR4在提高BCMA重定向CAR-NK细胞治疗多发性骨髓瘤的疗效方面发挥着双重作用

Moles, Michael W; Erdlei, Henry; Menzel, Lutz; Massaro, Marialucia; Fiori, Agnese; Bunse, Mario; Schrimpf, Moritz; Gerlach, Kerstin; Gudipati, Venugopal; Reiser, John; Mathavan, Ketan; Goodrich, Jodie P; Huppa, Johannes B; Krönke, Jan; Valamehr, Bahram; Höpken, Uta E; Rehm, Armin

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma

iPSC 衍生的 NK 细胞表达高亲和力 IgG Fc 受体融合 CD64/16A,介导针对淋巴瘤的灵活、多肿瘤抗原靶向治疗

Kate J Dixon, Kristin M Snyder, Melissa Khaw, Robert Hullsiek, Zachary B Davis, Anders W Matson, Soheila Shirinbak, Bryan Hancock, Ryan Bjordahl, Martin Hosking, Jeffrey S Miller, Bahram Valamehr, Jianming Wu, Bruce Walcheck